Medicine & Life Sciences
Ovarian Neoplasms
100%
Estrogen Receptors
59%
Poly(ADP-ribose) Polymerase Inhibitors
58%
Endometrial Neoplasms
40%
Syk Kinase
39%
Carcinoma
39%
Neoplasms
37%
Orphan Nuclear Receptors
36%
Platinum
36%
olaparib
32%
ERRalpha estrogen-related receptor
29%
Progression-Free Survival
28%
Therapeutics
26%
Papillomavirus Vaccines
19%
Drug Therapy
19%
Tamoxifen
19%
Survival
19%
Peroxisome Proliferator-Activated Receptors
18%
PM 01183
18%
rilotumumab
17%
T-Lymphocytes
17%
Liver
17%
brivanib
17%
Immunotherapy
16%
Uterine Cervical Neoplasms
16%
niraparib
16%
Ligands
16%
4,17 beta-dihydroxy-4-androstene-3-one
15%
Human papillomavirus type 16 E6 protein
15%
pyruvate dehydrogenase kinase 4
15%
Aromatase Inhibitors
14%
Hormones
14%
cabozantinib
14%
romidepsin
14%
Vaccination
14%
DNA Mismatch Repair
14%
trametinib
14%
Histone Deacetylase Inhibitors
14%
liposomal doxorubicin
13%
Hydrazones
13%
Topotecan
13%
Paclitaxel
13%
Pyruvate Dehydrogenase Complex
13%
Glutaminase
12%
Mutation
12%
Ovarian Epithelial Carcinoma
12%
DNA
12%
Fallopian Tubes
12%
Nivolumab
12%
Retinoid X Receptors
12%